MedRhythms, Inc. Email Format
Biotechnology ResearchMaine, United States51-200 Employees
MedRhythms, Inc. is a biotechnology research company based in Portland, Maine, focused on neurotherapeutics that combine music, sensors, software, and neuroscience to influence brain circuitry and improve walking and related mobility. The company is pursuing a pipeline of digital therapeutics for neurological conditions such as stroke, multiple sclerosis, and Parkinson's disease. Its approach targets neural pathways to enable functional improvements in patients. Recent developments include leadership changes and product initiatives. In July 2025, MedRhythms appointed Larry Jasinski as chief executive officer. In April 2025, it announced Movive for Parkinson's disease for Veterans. The company operates as a mid-sized biotechnology organization focused on expanding digital therapeutics to improve movement for individuals with neurological conditions.